Klotho Neurosciences regains full compliance with Nasdaq listing standards

12 hours ago 1
  • Klotho Neurosciences (NASDAQ:KLTO) received a notification letter from the Nasdaq Stock Market confirming that the company has regained compliance.
  • The company is now in full compliance with all NASDAQ continued listing requirements and will remain listed.

Recommended For You

More Trending News

Read Entire Article